IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiederholt, M.
Right arrow Articles by Hoffmann, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiederholt, M.
Right arrow Articles by Hoffmann, F.

Investigative Ophthalmology & Visual Science, Vol 27, 519-524, Copyright © 1986 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Pharmacokinetic of topical cyclosporin A in the rabbit eye

M Wiederholt, D Kossendrup, W Schulz and F Hoffmann

3H labelled cyclosporin A (CS-A) eye drops (2% in castor oil) were applied in rabbits. When a single drop of 10 microliters was given CS-A reached a maximal concentration of 900-1400 ng/ml in the cornea 6 hr after application and then slowly decreased. A substantial level of 600- 900 ng/ml was still present after 48 hr. When corneas were analysed for their cellular compartments, 67% of CS-A was found in the epithelium, 25% in the stroma (probably in keratocytes), and 8% in the endothelium. In corneas denervated by circular keratotomy, slightly reduced concentrations were found after surgery, the reduction was not therapeutically significant. Using the HPLC method a significant corneal metabolism of CS-A could be excluded. Scleral concentrations of CS-A as high as 180 ng/ml were found. Concentrations of CS-A in aqueous humor, lens, vitreous body and uvea/retina were below the therapeutic range.


This article has been cited by other articles:


Home page
IOVSHome page
T. Said, M. Dutot, R. Christon, J.-L. Beaudeux, C. Martin, J.-M. Warnet, and P. Rat
Benefits and Side Effects of Different Vegetable Oil Vectors on Apoptosis, Oxidative Stress, and P2X7 Cell Death Receptor Activation
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5000 - 5006.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
A. Leonardi, G. DeFranchis, I. A. Fregona, D. Violato, M. Plebani, and A. G. Secchi
Effects of Cyclosporin A on Human Conjunctival Fibroblasts
Arch Ophthalmol, October 1, 2001; 119(10): 1512 - 1517.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Kawazu, K. Yamada, M. Nakamura, and A. Ota
Characterization of Cyclosporin A Transport in Cultured Rabbit Corneal Epithelial Cells: P-Glycoprotein Transport Activity and Binding to Cyclophilin
Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1738 - 1744.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the Association for Research in Vision and Ophthalmology